150 related articles for article (PubMed ID: 38018657)
1. Fractional non-ablative assisted bimatoprost delivery: A synergistic approach for treating post-inflammatory hypopigmentation following cosmetic procedures in skin of color patients.
Jablon K; Theisen E; Hsu SH; Dover JS; Chung HJ
Lasers Surg Med; 2024 Jan; 56(1):11-13. PubMed ID: 38018657
[No Abstract] [Full Text] [Related]
2. Re-pigmentation of Hypopigmentation: Fractional Lasers vs Laser-Assisted Delivery of Bimatoprost vs Epidermal Melanocyte Harvesting System.
Waibel JS; Rudnick A; Arheart KL; Nagrani N; Gonzalez A; Gianatasio C
J Drugs Dermatol; 2019 Nov; 18(11):1090-1096. PubMed ID: 31738492
[TBL] [Abstract][Full Text] [Related]
3. Fractional Er:YAG Laser and 0.01% Bimatoprost in Leucoderma From Iatrogenic Melasma Treatment in a Skin Phototype V Patient.
Eimpunth S; Pacharapakornpong S; Yogya Y; Weiss MA
Dermatol Surg; 2023 Sep; 49(9):899-901. PubMed ID: 37389913
[No Abstract] [Full Text] [Related]
4. Open-label pilot study to evaluate the effectiveness of topical bimatoprost on rhododendrol-induced refractory leukoderma.
Fukaya S; Kamata M; Kasanuki T; Yokobori M; Takeoka S; Hayashi K; Tanaka T; Fukuyasu A; Ishikawa T; Ohnishi T; Iimuro S; Tada Y; Watanabe S
J Dermatol; 2018 Nov; 45(11):1283-1288. PubMed ID: 30156328
[TBL] [Abstract][Full Text] [Related]
5. Long-term Use of Topical Bimatoprost on Rhododendrol-induced Refractory Leukoderma: A Case Report.
Fukaya S; Kamata M; Kasanuki T; Yokobori M; Takeoka S; Hayashi K; Tanaka T; Fukuyasu A; Ishikawa T; Ohnishi T; Iimuro S; Watanabe S; Tada Y
Acta Derm Venereol; 2019 Nov; 99(12):1178-1179. PubMed ID: 31449314
[No Abstract] [Full Text] [Related]
6. Cutaneous hypopigmentation following a posterior sub-tenon triamcinolone injection.
Gallardo MJ; Johnson DA
Am J Ophthalmol; 2004 Apr; 137(4):779-80. PubMed ID: 15059734
[TBL] [Abstract][Full Text] [Related]
7. Reversible skin hypopigmentation after topical application of high potency glucocorticosteroids.
Piraccini BM; Gurioli C; Bruni F; Patrizi A
G Ital Dermatol Venereol; 2015 Dec; 150(6):759-61. PubMed ID: 26513047
[No Abstract] [Full Text] [Related]
8. Diagnosing Disorders of Hypopigmentation and Depigmentation in Patients with Skin of Color.
Ceresnie MS; Gonzalez S; Hamzavi IH
Dermatol Clin; 2023 Jul; 41(3):407-416. PubMed ID: 37236710
[TBL] [Abstract][Full Text] [Related]
9. Periorbital hypopigmentation and telangiectasias: Clues to diagnosing neonatal lupus in skin of color.
Kleitsch J; Mazori DR; Derrick KM; Uwakwe LN; Glick SA
Pediatr Dermatol; 2021 Nov; 38 Suppl 2():135-136. PubMed ID: 34250633
[TBL] [Abstract][Full Text] [Related]
10. Mexametric and cutometric assessment of the signs of aging of the skin area around the eyes after the use of non-ablative fractional laser, non-ablative radiofrequency and intense pulsed light.
Kołodziejczak AM; Rotsztejn H
Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 28220602
[TBL] [Abstract][Full Text] [Related]
11. Bimatoprost drug delivery with fractional laser and microneedling for the management of COVID-19 prone positioning-induced facial atrophy and hypopigmentation.
Wilson BN; Aleisa A; Menzer C; Rossi AM
JAAD Case Rep; 2021 Sep; 15():26-29. PubMed ID: 34307814
[No Abstract] [Full Text] [Related]
12. Common Dermatologic Procedures and the Associated Complications Unique to Skin of Color.
Adotama P; Papac N; Alexis A; Wysong A; Collins L
Dermatol Surg; 2021 Mar; 47(3):355-359. PubMed ID: 34328287
[TBL] [Abstract][Full Text] [Related]
13. Spectrophotometer is useful for assessing vitiligo and chemical leukoderma severity by quantifying color difference with surrounding normally pigmented skin.
Hayashi M; Okamura K; Araki Y; Suzuki M; Tanaka T; Abe Y; Nakano S; Yoshizawa J; Hozumi Y; Inoie M; Suzuki T
Skin Res Technol; 2018 May; 24(2):175-179. PubMed ID: 29057565
[TBL] [Abstract][Full Text] [Related]
14. [Cutaneous atrophy and hypopigmentation secondary to intra-articular corticosteroid injection].
Loarte Pasquel EP; Cabal García AA
Semergen; 2014 Apr; 40(3):e61-3. PubMed ID: 23583186
[TBL] [Abstract][Full Text] [Related]
15. Disfiguring Leukoderma Caused by Banned Cosmetics: A Quiz.
Atzori L; Zanniello R; Sarais G; Piras V; Pilloni L; Zucca M; Brundu MA; Rongioletti F
Acta Derm Venereol; 2018 Oct; 98(9):914-915. PubMed ID: 29944166
[No Abstract] [Full Text] [Related]
16. Shining Light on Autophagy in Skin Pigmentation and Pigmentary Disorders.
Kovacs D; Cardinali G; Picardo M; Bastonini E
Cells; 2022 Sep; 11(19):. PubMed ID: 36230960
[TBL] [Abstract][Full Text] [Related]
17. Chemical and pharmacologic agents that cause hyperpigmentation or hypopigmentation of the skin.
Lerner EA; Sober AJ
Dermatol Clin; 1988 Apr; 6(2):327-37. PubMed ID: 3288388
[TBL] [Abstract][Full Text] [Related]
18. Hypopigmentation of the skin due to imatinib mesylate in patients with chronic myeloid leukemia.
Aleem A
Hematol Oncol Stem Cell Ther; 2009; 2(2):358-61. PubMed ID: 20118061
[TBL] [Abstract][Full Text] [Related]
19. Fractional Resurfacing and Topical Bimatoprost for the Treatment of Laser Induced Postinflammatory Hypopigmentation on the Lower Extremities.
Regis A; MacGregor J; Chapas A
Dermatol Surg; 2018 Jun; 44(6):883-886. PubMed ID: 28961640
[No Abstract] [Full Text] [Related]
20. Pediatric disorders of pigmentation commonly seen in skin of color.
Ascha M; Irfan M
Semin Cutan Med Surg; 2016 Dec; 35(4):191-200. PubMed ID: 27918000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
